X4 Pharmaceuticals, Inc.
XFOR
Price:
$0.338
Market Cap:
$57.64M
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase Ib clinical trial to treat chronic neutropenia and Waldenström macroglobulinemia. The company is also developing X4P-002, a CXCR4 antagonist for the treatment of brain cancers; and X4P-003, a CXCR4 antagonist for the t...[Read more]
Industry
Biotechnology
IPO Date
2017-11-16
Stock Exchange
NASDAQ
Ticker
XFOR
PE Ratio
[-4.23]
ROE
[-32.51%]
Current Ratio
[4.89]
Dividend Yield
[0%]
Enterprise Value
[38.44M]
Dividend History
The ROE as of November 2024 (TTM) for X4 Pharmaceuticals, Inc. (XFOR) is -32.51%
According to X4 Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current ROE is -32.51%. This represents a change of -97.40% compared to the average of -1249.88% of the last 4 quarters.
X4 Pharmaceuticals, Inc. (XFOR) Historical ROE (quarterly & annually)
How has XFOR ROE performed in the past?
The mean historical ROE of X4 Pharmaceuticals, Inc. over the last ten years is -85.48%. The current -32.51% ROE has changed -61.97% with respect to the historical average. Over the past ten years (40 quarters), XFOR's ROE was at its highest in in the June 2024 quarter at 96.17%. The ROE was at its lowest in in the March 2024 quarter at -4996.72%.
Average
-85.48%
Median
-85.35%
Minimum
-199.17%
Maximum
40.62%
X4 Pharmaceuticals, Inc. (XFOR) ROE by Quarter and Year
Discovering the peaks and valleys of X4 Pharmaceuticals, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 245.15%
Maximum Annual ROE = 40.62%
Minimum Annual Increase = -242.06%
Minimum Annual ROE = -199.17%
| Year | ROE | Change |
|---|---|---|
| 2023 | -197.98% | 56.19% |
| 2022 | -126.76% | -7.95% |
| 2021 | -137.70% | 61.34% |
| 2020 | -85.35% | 94.83% |
| 2019 | -43.80% | -78.01% |
| 2018 | -199.17% | 245.15% |
| 2017 | -57.71% | -242.06% |
| 2016 | 40.62% | 5.47% |
X4 Pharmaceuticals, Inc. (XFOR) Average ROE
How has XFOR ROE performed in the past?
The current ROE of X4 Pharmaceuticals, Inc. (XFOR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-154.15%
5-year avg
-118.32%
10-year avg
-85.48%
X4 Pharmaceuticals, Inc. (XFOR) ROE vs. Peers
How is XFOR’s ROE compared to its peers?
X4 Pharmaceuticals, Inc.’s ROE is greater than Terns Pharmaceuticals, Inc. (-32.76%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than PDS Biotechnology Corporation (-139.57%), greater than Inozyme Pharma, Inc. (-88.42%), greater than Acumen Pharmaceuticals, Inc. (-32.99%), greater than Mereo BioPharma Group plc (-69.11%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Elevation Oncology, Inc. (-59.73%), greater than Hepion Pharmaceuticals, Inc. (-505.74%), greater than HOOKIPA Pharma Inc. (-49.25%),
| Company | ROE | Market cap |
|---|---|---|
| -32.76% | $491.80M | |
| -22.40% | $1.38B | |
| -139.57% | $78.19M | |
| -88.42% | $180.51M | |
| -32.99% | $142.39M | |
| -69.11% | $575.61M | |
| 2.18% | $941.00 | |
| -59.73% | $35.67M | |
| -505.74% | $4.62M | |
| -49.25% | $20.76M |
Build a custom stock screener for X4 Pharmaceuticals, Inc. (XFOR) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like X4 Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
X4 Pharmaceuticals, Inc. (XFOR) and other stocks custom spreadsheet templates
The easiest way to analyze a company like X4 Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is X4 Pharmaceuticals, Inc.'s ROE?
How is the ROE calculated for X4 Pharmaceuticals, Inc. (XFOR)?
What is the highest ROE for X4 Pharmaceuticals, Inc. (XFOR)?
What is the 3-year average ROE for X4 Pharmaceuticals, Inc. (XFOR)?
What is the 5-year average ROE for X4 Pharmaceuticals, Inc. (XFOR)?
How does the current ROE for X4 Pharmaceuticals, Inc. (XFOR) compare to its historical average?